Stanislaw Burzynski, MD, PhD, is a medical doctor and biochemist practicing oncology in Texas who developed (using his own money) a nontoxic gene-targeted cancer therapy called antineoplastons. It has been shown to effectively help cure some of the most “incurable” forms of terminal cancer. From my perspective, Dr. Burzynski represents the essence of an ideal physician. When faced with a disease process (in this case cancer) for which there is not yet a clear cure, he thinks about the process from a mechanistic perspective, measures specific biomarkers (well based in research though not yet "endorsed" by the medical system), and designs a therapy that makes biological sense using all legal means at his disposal. All Dr. Burzynski's patients are aware that he works outside the "conventional box"; they seek him out for this reason, often presenting late in their disease process because nothing else has worked. Dr. Burzynski sees many positive results with his therapies, even with cancers that are known to be resistant to current conventional approaches. There is no approach that cures everything, and the same is true for Dr. Burzynski's methods but his results are very impressive.
In the 1980s the Texas Medical Board (TMB) charged him with breaking a law that didn’t actually exist and tried to revoke his medical license. Numerous investigations later—including an appearance before the Texas Supreme Court—no violation of any law or standard of care was found. The TMB came up empty-handed. Other federal government agencies also attacked Dr. Burzynski and spent over $60 million to prosecute him on 75 counts of violating federal law, hoping to tuck him away in jail for the rest of his life. Dr. Burzynski was engaged in a lengthy (over 10 years) and convoluted legal battle with the FDA. After two trials, he was found not guilty on all counts, and his antineoplastons medication is currently undergoing the FDA approval process. His fight was chronicled in a stunning documentary film, Burzynski: The Movie. More info on the documentary can be found at the film’s website, while the movie itself can be viewed online for a limited time.
This pioneering cancer doctor is now a target once again. The TMB is making yet another attempt to revoke Dr. Burzynski’s medical license which, if successful, would result in the closure of his clinic, the abandonment of all his patients, and would squelch any possibility of antineoplastons gaining FDA-approval. Using the death of two of his terminally ill patients as a pretext, the TMB is charging Dr. Burzynski with the off-label use of FDA-approved drugs. It must be stressed, however, that Dr. Burzynski uses the drugs off-label in order to tailor the medication specifically to the biomarkers he measures from his patients' blood and tissue samples, rather than using a one-size-fits-all approach. Even though the American Society of Clinical Oncology has stated that they want to focus on “targeted therapies and personalized diagnosis and treatment” over the next decade, Dr. Burzynski is one of the few doctors taking this approach with patients today and the only one doing it is such an open way. The TMB’s complaint concerns one patient who had triple-negative breast cancer, had already undergone conventional cancer treatment without success, and initially felt better after Dr. Burzynski’s treatment and was able to return to work. The board is charging Dr. Burzynski over the side effects of his treatment, though they do not seem concerned with the horrible side effects she experienced with the conventional cancer treatments. The complaint also concerns another patient with estensioneruoblastoma, a cancer so rare that any medication used is “off-label” since there is no recognized treatment for this disease. The patient lived for five more years and the tumor decreased in size by 40%, but the TMB complaint is charging that the disease actually progressed during his treatment.
The off-label use of FDA-approved drugs is not uncommon, and it is legal. According to the American Cancer Society, a study showed that 8 out of 10 cancer doctors surveyed had used drugs off-label. And half of the chemotherapy drugs used are for conditions not listed on the FDA-approved drug label.
Please consider taking 20 minutes to watch this brand-new video on the upcoming court case, and share it with anyone you believe might be interested. It outlines the charges involved in the case, and gives you a glimpse at a new side of Dr. Burzynski’s treatment. It is shocking how flimsy the TMB’s case is—and how doggedly persistent the board is in harassing Dr. Burzynski. The Texas Medical Board v. Stanislaw Burzynski trial begins April 11, 2012 and you can help by telling the Texas Legislative Committees and Governor Rick Perry, who over see the Texas Medical Board, to stop the Medical Board's attack. This is about our right as citizens to have a choice in cancer treatment. It is about saving decades of important molecularly targeted cancer research from being stifled in the name of protecting the profits of an industry that doesn’t want Dr. Burzynski's clinic to survive. Please take action to save this farsighted and courageous doctor and the therapies that have helped so many of his patients.